Match!
Jill Graham
Beatson West of Scotland Cancer Centre
CancerBiliary tractChemotherapyCapecitabineOxaliplatin
3Publications
1H-index
2Citations
What is this?
Publications 5
Newest
#1T.R. Jeffry Evans (Beatson West of Scotland Cancer Centre)H-Index: 33
#2Martin Eatock (Belfast City Hospital)H-Index: 10
Last. M. Ashton (Beatson West of Scotland Cancer Centre)H-Index: 1
view all 19 authors...
709Background: Olaparib is a potent inhibitor of PARP-1, which has a critical role in signalling DNA single strand breaks (SSB) as part of the base excision repair pathway, and may have radio-sensi...
Source
#1Kristen Keon Ciombor (VUMC: Vanderbilt University Medical Center)H-Index: 14
#2Janet Shirley Graham (Beatson West of Scotland Cancer Centre)H-Index: 13
Last. Josep Tabernero (Hebron University)H-Index: 90
view all 13 authors...
TPS274Background: Although 5-FU-based regimens such as FOLFOX and FOLFIRI remain the cornerstone of treatment for patients (pts) with colorectal cancer (CRC), their clinical utility is limited by r...
Source
#1Jill Graham (Beatson West of Scotland Cancer Centre)H-Index: 1
#2K. Boyd (Beatson West of Scotland Cancer Centre)H-Index: 1
Last. T. R. J. Evans (Glas.: University of Glasgow)H-Index: 1
view all 11 authors...
Background Advanced biliary tract carcinomas are associated with a poor prognosis, and palliative chemotherapy has only modest benefit. This multi-centre phase II study was conducted to determine the efficacy of capecitabine in combination with oxaliplatin in patients with inoperable gall bladder or biliary tract cancer.
1 CitationsSource
#1R. Rulach (Beatson West of Scotland Cancer Centre)H-Index: 3
#2J. Evans (Beatson West of Scotland Cancer Centre)H-Index: 6
Last. Janet Shirley Graham (Beatson West of Scotland Cancer Centre)H-Index: 13
view all 9 authors...
3 CitationsSource
#1Janet Shirley Graham (Beatson West of Scotland Cancer Centre)H-Index: 13
#2Nigel B. Jamieson (Glas.: University of Glasgow)H-Index: 35
Last. Ross Carter (Glasgow Royal Infirmary)H-Index: 22
view all 11 authors...
Source
1